Supreme Court turns down Martin Shkreli's latest appeal, leaving 'pharma bro' to 7-year sentence

Martin Shkreli will continue to serve out his sentence after the latest appeal to overturn his conviction was rejected by the Supreme Court.

Better known outside biotech circles as “pharma bro,” Shkreli was sentenced to seven years in federal prison on three felony fraud convictions relating to two hedge funds and one biotech, Retrophin, he founded. The Supreme Court justices refused to hear his appeal, which would have also involved a $7.36 million forfeiture.